Related references
Note: Only part of the references are listed.Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme
Hsiu-Yin Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study
Marcelle D. Alves et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: MIC Matters
Nan-Yao Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification
John S. Esterly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of Antibiotic MIC on Infection Outcome in Patients with Susceptible Gram-Negative Bacteria: a Systematic Review and Meta-Analysis
Matthew E. Falagas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Does the Piperacillin Minimum Inhibitory Concentration for Pseudomonas aeruginosa Influence Clinical Outcomes of Children With Pseudomonal Bacteremia?
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2012)
A model to predict mortality following Pseudomonas aeruginosa bacteremia
Elizabeth B. Hirsch et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa
Yuka Yamagishi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia
Anthony M. Nicasio et al.
JOURNAL OF CRITICAL CARE (2010)
Effect of Differences in MIC Values on Clinical Outcomes in Patients with Bloodstream Infections Caused by Gram-Negative Organisms Treated with Levofloxacin
Robyn DeFife et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
James H. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2009)
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States
R. Monina Klevens et al.
CLINICAL INFECTIOUS DISEASES (2008)
Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam:: Implications on the appropriateness of the resistance breakpoint
Vincent H. Tam et al.
CLINICAL INFECTIOUS DISEASES (2008)
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Andrea Endimiani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms
Sunil V. Bhat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units
Juliana F. Roos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The impact of antimicrobial resistance on health and economic outcomes
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Meropenem:: clinical response in relation to in vitro susceptibility
GL Drusano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2000)
Share Paper
